Neuroinflammation is a hallmark of Alzheimer’s and Parkinson’s Disease in neurohistological and neuroimaging studies. Recently, multiple disease genes and risk factors have been identified as modulators of immune function in AD and PD (1, 2).
At discoveric bio gamma we develop novel antibody-based therapeutics to modulate neuroinflammation for neurodegenerative diseases.
Sources: